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Conditional TVAAn understanding of the number and types of progeny produced by progenitor cells during development
provides a foundation for studies of when and where cell fate determination takes place. Lineal relationships
can be revealed by the identiﬁcation of descendents of cells that express a recombinase, such as Cre or Flp. This
method provides data concerning gene expression history, but does not provide clonal resolution among the
descendents. An alternative method employs retroviral labeling, which permits the identiﬁcation of clones,
but does not allow for the tracking of gene expression history. Here we report a combination of these methods
to circumvent each method's limitations. By employing the speciﬁcity of Cre expression, and by selecting only
a subset of cells with a Cre history for retroviral infection, cloneswith a gene expression history can be labeled.
The method utilizes a conditional allele of the avian tumor virus receptor A (TVA), which allows infection of
mouse cells following Cre activity, withmammalian retroviral vectors pseudotyped with the ASLV-A envelope
glycoprotein (EnvA). We quantiﬁed the efﬁciency and speciﬁcity of this system in vivo and in vitro. We also
generated a series of retroviral vectors encoding a variety of histochemical and ﬂuorescent reporter genes that
enable the tracking of mixtures of clones, thus enabling better resolution of clonal boundaries. This method
and new vectors can be used to further our understanding of the gene expression patterns of progenitor cells
that make particular daughter cells, as well as provide a platform for manipulating identiﬁed subsets of
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One of the challenges to understanding the development of
multicellular organisms is determining the relationship between gene
expressionand cell fate decisions. Tobegin to address this challenge, one
can determine the progenitor–progeny relationships, i.e. perform
lineage analyses of developing cells. This descriptive exercise can
provide insights into when and where decisions are being made
concerning cell fates. The link to gene expression patterns can be
provided by marking cells that are expressing a particular gene, or
marking cells with a particular gene expression history. Engineered
expressionof the recombinases, Cre and Flp, has provided a powerful set
of tools for this latter purpose, and has provided a means to perform
tissue-speciﬁc loss or gain of function analyses (Kim and Dymecki,
2009). In most cases of engineered recombinase expression, the
regulatory elements employed to direct recombinase expression leadto the labeling of a fairly broad spectrum of daughter cell types. Labeled
descendents typically comprise multiple cell types, with unclear clonal
relationships among the labeled cells. One approach to improve the
resolution of this method has been the intersectional method, in which
Cre and Flp mouse lines are crossed to a Cre- and Flp-sensitive reporter
line. Only cellswithanexpressionhistory of bothCre andFlp express the
reporter gene, permitting the labeling of amore restricted group of cells
which share ahistory of expressionof twogenes (Farago et al., 2006).An
additional limitation in recombinase fate mapping is due to the lack of
control of the timing of recombinase action. Unless one uses a regulated
recombinase, such as an estrogen receptor fusion of Cre (Metzger et al.,
1995), one cannot choose the time to initiate labeling. The lack of timing
control can create an ambiguity regarding whether a labeled cell is a
descendent of a Cre-expressing progenitor cell, orwhether a labeled cell
became marked following Cre expression later in its development.
Another approach that can be used to obtain speciﬁcity in the
marking of descendents is the EnvA/TVA system.Mice are not infectable
with viruses carrying the EnvA glycoprotein from avian retroviral
vectors (Weiss et al., 1985). However, since the discovery of the avian
TVA, which encodes the receptor for EnvA, mouse strains have been
created that allow infection by EnvA vectors through expression of TVA
inmurine tissues (Federspiel et al., 1994; Lewis et al., 2001; Young et al.,
1993). This method has been productively employed previously for
several applications (Doetsch et al., 1999; Federspiel et al., 1994; Fisher
Fig. 1. Experimental strategy for use of the cTVA allele for lineage analysis. A mouse with
conditional expression of TVA can be crossed to a Cre line of choice, with expression of Cre
directed by a tissue-speciﬁc promoter (TSP). TVA, a receptor for viruses with the EnvA
glycoprotein, will be expressed in cells with a history of Cre expression. Viruses
pseudotyped with the EnvA glycoprotein are able to infect TVA-expressing cells, and are
not able to infect non-TVA expressing mouse cells. Viruses pseudotyped with the VSV-G
glycoprotein can infect anymitotic cell. Two viruses, onepseudotypedwith EnvA, encoding
PLAP, and one pseudotypedwith VSV-G, encoding lacZ, can be coinjected into a developing
tissue, e.g. the eye. The drawings in A and B depict retinal sections following histochemical
processing for PLAP (purple) and β-galactosidase (blue). (A). If a control, TVA-negative
retina is injectedwith amixture of the two viruses, only blue cloneswill result. (B) If a TVA
expressing retina is injected with this mixture of viruses, both types of viruses will infect
mitotic cells, giving rise to blue and purple clones. In this example, the cells with a Cre
history generate clones of rod photoreceptors (R) and amacrine interneurons (Am).
310 K.T. Beier et al. / Developmental Biology 353 (2011) 309–320et al., 1999; Holland et al., 1998;). For each study, independent mouse
lines have been generated to express TVA under the control of different
promoters. This approach is both time and labor-intensive, as each
transgenic line needs to be generated and characterized for each set of
experiments. Recently, Seidler et al. reported the production of a mouse
permitting conditional expression of TVA (Seidler et al., 2008).We have
independently generated three mouse lines conditionally expressing
TVA and have demonstrated their utility in tracking clones with a
particular gene expression history. Thismethod combines the strengths
of the recombinase fate mapping strategy and the clonal resolution
afforded by retroviral lineage analysis. In addition, the fact that the viral
vectors used for lineage analysis can only infect mitotic cells provides
a guarantee that cells that aremarked came fromaprogenitor cellwith a
history of Cre expression, andwere not labeled by expression of Cre at a
later point in their development.
We have performed quantitative analyses of the efﬁcacy and
speciﬁcity of this method. These studies are crucial, as infectability
must be restricted to Cre-expressing/TVA expressing cells, or gene
expression cannot be correlated with clonal labeling. We report that
infectability is indeed restricted to cells with a Cre expression history in
vivo. Interestingly, we also discovered a “hitchhiking” phenomenon
whereby mixtures of virions with different envelope proteins can use
each other's envelope proteins to gain access to host cells. Finally,
we report the development of several retroviral vectors encoding
discrete histochemical and ﬂuorescent markers for distinctive labeling
of multiple clones, to aid in the deﬁnition of clonal boundaries, and to
give ﬂexibility in terms of labeling protocols.
Materials and methods
Viruses and virus production
All EnvA viruses were produced in 293T cells (Cepko and Pear, 2001;
Pear et al., 1993). Viruses encoding genes for histochemical analysis
includeLIA,whichencodeshumanplacental alkalinephosphatase (PLAP)
(Bao andCepko, 1997), BAG,which encodesβ-galactosidase (lacZ) (Price
et al., 1987), and NinII, which is similar to LIA but encodes a nuclear lacZ
gene in place of PLAP. All viruses encoding ﬂuorescent reporters were
derived from the pQCXIX vector (Clontech). To produce the EnvAviruses,
on Day 1, at 70% conﬂuency, a 10 cm plate was transfectedwith a pool of
plasmids containing 6 μg viral genomic plasmid, 3 μg pMD gagpol
plasmid (Ory et al., 1996), and 1 μg EnvA envelope plasmid (Landau
and Littman, 1992). Media was changed the following day and replaced
with 5 mL of freshmedia. On days 3 and 4, the supernatantwas collected
and frozen. Supernatants were thawed and viruses concentrated by
ultracentrifugation (Cepko and Pear, 2001). Themethod of production of
VSV-G enveloped viruses was the same, except they were produced in
the platE cell line, which expresses gagpol and the ecotropic envelope
gene (Morita et al., 2000;Naldini et al., 1996). In this case, 1 μg of pCLVSV
(gift from Richard Mulligan, Harvard Medical School) was transfected
into platE cells together with 6 μg of genomic plasmid.
Cell culture
For cell culture experiments, NIH 3T3 cells were grown to
conﬂuency on a 10 cm plate, and split onto 6-well plates at a 1:20
surface area split ratio. Each condition was done in triplicate. The next
day, the cells were transfected with 5 μg of total DNA using FUGENE6
(Roche) according to the manufacturer's instructions. In order to
maintain a constant FUGENE:DNA ratio, for the cTVA and CAG-Cre:GFP
(Matsuda and Cepko, 2007) combination, 2.5 μg of each plasmid was
co-transfected,whereas for CAG-TVA, UbC-cTVA (cTVA), andCAG-Cre:
GFP, 2.5 μg of plasmid was co-transfected with 2.5 μg of pBluescript II
KS(−) (genbank accession number X52329). The day after transfec-
tion, each well was infected with NinII containing the EnvA protein on
its envelope (NinII(EnvA)) or QCXIX encoding a nuclear form oftdTomato cloned 5′ of the Ires (QC NLS-tdTomato IX (EnvA)). Xgal
assays were performed as described (Price et al., 1987), and tdTomato
ﬂuorescence was observed by ﬂuorescent microscopy. Transfection
efﬁciency of NIH 3T3 cells was measured by transfecting a nuclear
localized green ﬂuorescent protein (CAG-Cre:GFP) and, three days
following transfection, comparing GFP positive nuclei to the 4′,6-
diamidino-2-phenylindole (DAPI)-positive nuclei. Co-transfection
ratios were calculated by co-transfecting CAG-GFP:Cre along with
pCALNL DsRed (a reporter plasmid for Cre activity encoding DsRed,
Matsuda and Cepko, 2007) and comparing cells that were both green
and red (express genes from both plasmids) to those that were only
green (expressing GFP:Cre).
For MEF cultures, 10 cm conﬂuent tissue culture plates were split 1:6
onto 10 cm plates, and infected 8 h after splitting with NinII(EnvA). Cells
wereglutaraldehydeﬁxed3 days later andXgal stained, asdetailedbelow.
Mice
Each of the three cTVA transgenic lines was created by pronuclear
injection. Each line was maintained as heterozygotes. The construct
used for injection is as shown in Fig. 1. The human ubiquitin-C (UbC)
promoter is a broadly active promoter which should drive expression
of a gene (in this case, destabilized GFP) in all or most cells in the
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only be expressed after Cre has recombined out the upstream GFP. A
transcriptional stop prevents transcription of the TVA gene until Cre
has acted. GFP expression in mice with cTVA in the absence of Cre
should provide evidence of where and when the construct is
expressed. However, we were unable to detect GFP in any of the
lines, presumably due to the use of the destabilized GFP allele and/or
low level expression. For genotyping, primers were designed to the
UbC promoter, as follows: 5′-GAGCGGAACAGGCGAGGAAAAGTA-3′
and 5′-CGCCCCCGCAACCAGACGACAA-3′. The amplicon is 554 bp. The
Chx10-Cre (Rowan and Cepko, 2004), hβactin-Cre (Lewandoski and
Martin, 1997), and Wnt1-Cre (Danielian et al., 1998) mice were
maintained as heterozygotes. Genotyping primers for each Cre line are
as follows: 5′-GCAGAACCTGAAGATGTTCGC-3′ and 5′-ACACCAGAGAC-
GGAAATCC-3′. The amplicon is 494 bp.
Quail TVA (pg800, (Bates et al., 1993)) was generated by RT-PCR
using the primers 5′-AAGAATTCTGAGCCGCCACCATGGCGCGG-
CTGCTGCCCGCGCTG-3′ and 5′-ATATGCGGCCGCTCACTCAGTCCCATCT-
CACCAGCTCACAGCAA-3′ and RNA isolated from quail ﬁbrosarcoma
QT6 cells (ATCC #. CRL-1708). The PCR ampliﬁed fragment was digested
with EcoRI/NotI and cloned into pCAGEN ((Matsuda and Cepko, 2007),
addgene #11160) digested with EcoRI/NotI to make pCAG-TVA.
LoxP-GFPd2 was generated by PCR using the primers 5′-
ATGCACGCGTATAACTTCGTATAGCATACATTATACGAAGTTATGGATCCA-
CCGGTCGCCACCAT-3′ and 5′-GAGTCGCGGCCGCGCATCTACACATT-
GATCC-3′ and pCAG-GFPd2 ((Matsuda and Cepko, 2007), addgene
#14760) as a template. SV40polyA-loxPwas generated by PCR using the
primers 5′-ATGCGCGGCCGGGACTCTAGATCATAATCAGCCATACCAC-3′
and 5′-TTCTCGAGATATAACTTCGTATAATGTATGCTATACGAAG-
TTATCGCCTTAAGATACATTGATGAG-3′ and pCALNL-GFP ((Matsuda
and Cepko, 2007), addgene #13770) as a template. To make CAG-loxP-
GFPd2-SV40polyA-loxP-GFP (pCALGd2L-GFP), these two PCR fragments
were digested with MluI/EagI and EagI/XhoI, respectively, and simulta-
neously ligated into pCALNL-GFP digested with MluI/XhoI. To make
human UbC promoter-loxP-GFPd2-SV40polyA-loxP-GFP (pUbCLGd2L-
GFP), loxP-GFPd2-SV40polyA-loxP-GFP was excised from pCALd2L-GFP
withMluI (blunt ended) andNotI, and ligated into pUbC-GFP ((Matsuda
and Cepko, 2004), addgene #11155) digested with SacI (blunt ended)
and NotI. To make pUbCLGd2L-TVA, the coding region of TVA excised
from pCAG-TVA with EcoRI and NotI (blunt ended) was ligated into
pUbCLGd2L-GFP digested with EcoRI and Sau36I (blunt ended). The
expression cassette UbCLGd2L-TVAwas isolated as a SspI (blunt ended)/
SﬁI fragment, and inserted into the XhoI site (blunt ended) of pBS-Ins4s
obtained from Dr. David Rowitch (UCSF) to ﬂank UbCLGd2L-TVA with
the chicken β-globin HS4 insulators (1.2 kb HS4, (Chung et al., 1993)).
The insulated UbCLGd2L-TVA was isolated as a NotI fragment, and
injected into the pronuclei of fertilized SJL-BL/6 F1 blastocysts and
backcrossed into the C57BL/6 strain. All experiments involving mice
were approved by the LongwoodMedical Area Institutional Animal Care
andUse Committee. All three cTVAmouse strains are currently available
at The Jackson Laboratory (Stock #015805, 015806, and 015807). An
additional strain that has been crossed to hβactin-Cre for constitutive
TVA expression is also available (Stock #015808).
Retinal injections and dissections
Mouse pupswere injected subretinally at P0 and sacriﬁced at P21 as
described previously (Turner and Cepko, 1987). For quantiﬁcation of
EnvA:VSV-G efﬁciency in the retina, 500 nL of a mixture of 1×107 cfu/
mL LIA(EnvA) and 5×106 cfu/mL BAG(VSV-G) were used. Dilutions of
1:5 and 1:25 of this mixture were used for sparser retinal infection.
Retinae were processed according to the staining or viral detection
protocol required for the marker gene. β-galactosidase and PLAP
histochemical staining protocols were conducted as previously described
(Fields-Berry et al., 1992; also see http://genetics.med.harvard.edu/
~cepko/protocol/xgalplap-stain.htm). Whole eyeballs were ﬁxed in 0.5%glutaraldehyde for 20 min for Xgal stain, and 4% formaldehyde for 1 h for
PLAP or ﬂuorescent analysis. The retinal pigmented epithelium (RPE) and
lenswere removedafterﬁxation. Retinaewerepost-ﬁxed for 15 min, then
rinsed three times for 15′ each in PBS. For ﬂuorescent analysis, antibody
stainingwas conducted as previously described (Punzo andCepko, 2008).
For confocal and clone counting analyses, retinaewere ﬂatmounted
between cover slips. After histochemical or immunohistochemical
processing, retinae were rinsed 3 times in PBS for 15 min, then cut 4
times so as to lay ﬂat. Retinae were mounted with ﬂuoromount
(Southern Biotech) for β-galactosidase and PLAP detection or Prolong
Gold for ﬂuorescence detection.
For experiments onmouse retinal explants, retinaewere taken from
P0mice, and cultured on ﬁlters as previously described (Altshuler et al.,
1993). Retinae were immediately infected with either 1 μL of 2.7×104
infectious BAG(EnvA) virions or 1 μL of a mixture of 2.7×104 BAG
(EnvA) and 1.35×104 LIA(VSV-G) virions. Retinae were maintained for
three days in vitro, ﬁxed, and stained for β-galactosidase only.
For postnatal brain injections of cTVA×hβactin-Cre animals, P2mice
were injected into themidbrain with 1 μL of amixture of 5×108 cfu/mL
LIA(EnvA) and 1×108 NinII(EnvA). Mice were perfused with 4% PFA at
P28, and brains were stained histochemically for both β-galactosidase
and PLAP activities. For prenatal brain injections of cTVA×Wnt1-Cre
animals, pups were injected in utero into the junction of the third and
fourth ventricles at embryonic day 13.5 using ultrasound-guided
injection (Punzo and Cepko, 2008). Two different viral solutions were
injected, a 200 nL mixture of 1×109 cfu/mL LIA(EnvA) and 5×108 cfu/
mL NinII(EnvA), or 200 nL of 1×1010 cfu/mL QC NLS-GFP IX(EnvA).
Mice were sacriﬁced at P0, ﬁxed with 4% PFA, and examined for PLAP
enzyme activity, β-galactosidase enzyme activity, or immunohisto-
chemically detectable GFP.
Antibodies:Primary antibody Dilution SourcePrimary antibodies
Chicken anti-GFP (GFP) (ab13970) 1:2000 Abcam
Rabbit anti-DsRed (tdTomato) (632496) 1:1000 Clontech
Goat anti-β-galactosidase (4600–1409) 1:400 AbD SerotecSecondary antibodies
Goat anti-rabbit Cy3 (tdTomato)
(111-165-003)1:250 Jackson
ImmunoresearchGoat anti-chicken A488 (GFP)
(103-485-155)1:250 Jackson
ImmunoresearchDonkey anti-rabbit Cy3 (tdTomato, mCherry)
(711-165-152)1:250 Jackson
ImmunoresearchDonkey anti-goat Cy5 (β-galactosidase)
(705-495-003)1:250 Jackson
ImmunoresearchDonkey anti-goat A488 (β-galactosidase)
(705-485-147)1:250 Jackson
ImmunoresearchResults
Test of infectivity of murine cells with EnvA pseudotyped retroviruses
Mammalian cells have been shown to be uninfectable with retro-
viruses carrying the EnvA protein in the viral envelope (Federspiel et al.,
1994; Weiss et al., 1985; Young et al., 1993). However, mouse cells can
be made infectable by introduction of the TVA receptor. In order to
conﬁrm these ﬁndings and quantify the speciﬁcity and efﬁciency of use
of the transgenic cTVA mice that we constructed, we ﬁrst performed
control experiments. TwodifferentTVAexpressionvectorswere created
using two different broadly active promoters: CAG-TVA and hUbC-loxP-
GFP-stop-loxP-TVA (cTVA). The CAG-TVA expresses the TVA receptor
ubiquitously using the CAG promoter (Niwa et al., 1991), while cTVA
uses the ubiquitous human ubiquitin C promoter (Lois et al., 2002;
Schorpp et al., 1996), and is expressed only after a Cre-mediated
recombination event.
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were examined for infectivity with an EnvA pseudotyped murine
retrovirus following transfection of several types of plasmids. For a
positive control, theywere transfectedwithCAG-TVA. To test for activity
of cTVA, they were transfected with both cTVA and CAG-GFP:Cre. Two
negative controls were used, one with cTVA in the absence of GFP:Cre,
and one with GFP:Cre in the absence of cTVA. Transfected cells were
inoculated a day later with the NinII(EnvA) murine retrovirus, which
encodes nuclear β-galactosidase, or QC NLS-tdTomato IX(EnvA).
Infected cells were scored for expression of β-galactosidase by Xgal
histochemistry, or for tdTomato by its intrinsic ﬂuorescence. Clones
were identiﬁed as a coherent cluster of labeled cells surrounded by
unlabeled cells. More clones were observed when CAG-TVA alone was
transfected than when cTVA+CAG-GFP:Cre were co-transfected
(Fig. 2). Many more clones were observed following infection of cells
transfected with cTVA+GFP:Cre than cTVA or GFP:Cre alone. The
efﬁciency of infection for each transfection was calculated as the
number of clones relative to infectious particles, which had been
measured on a 293 cell line, TVA800, constitutively expressing TVA
(Narayan et al., 2003). The efﬁciency for CAG-TVA was 6.08×10−2 and
for cTVA+GFP:Cre was 1.27×10−2. The number of infections of cells
transfected with cTVA alone or CAG-Cre alone was not zero. These
efﬁciencieswere 3.28×10−4 for cTVAaloneand2.60×10−4 forGFP:Cre
alone.
It should be noted that all measured efﬁciencies not only reﬂect
the efﬁciency of the viral events, but also the efﬁciency of transfectionFig. 2. Infection of murine NIH 3T3 cells with EnvA pseudotyped retroviruses. Mouse NIH 3T3
or CAG-GFP:Cre. The next day, they were infected with MMLV retroviruses pseudotyped wit
histochemistry. (B) An image of a single ﬂuorescent NLS-tdTomato-infected clone (red) w
observed on the transfected cells vs. the number of infectious particles observed on 293T TV
corresponding values shown in the table below. The number of infections in the cTVA alone oof 3T3 cells, which was observed to be approximately 1% (Supple-
mental Fig. 1). It was possible that the lower efﬁciency of infection of
the cTVA+GFP:Cre transfected cells was due to lack of recombination
of the cTVA construct. To measure how well Cre from this construct
was able to recombine a plasmid template, and to measure the co-
transfection rates, another experiment was performed. pCAG-GFP:Cre
was co-transfected with pCALNL-DsRed, which expresses DsRed only
in cells having a Cre expression history (Matsuda and Cepko, 2007).
The cells expressing Cre-GFP were then examined for expression of
DsRed. It was observed that 230/230 GFP:Cre expressing-cells also
expressed DsRed (Supplemental Fig. 1), indicating that Cre was active
in all cells expressing GFP:Cre. Low efﬁciency of Cre activity would
thus not explain the difference between infectivity of CAG-TVA
transfected cells and cTVA transfected cells.
Characterization of transgenic mouse lines with conditional TVA expression
For use in a developmental context, transgenic mouse lines were
generated to allow for expression of TVA following a Cre-mediated
recombination event. The same cTVA plasmid that was tested in NIH
3T3 cells was used to establish three separate cTVA transgenic lines by
pronuclear injection, designated L1, L2, and L3.
To test the effectiveness and ﬁdelity of the conditional allele in the
three mouse lines, each line was crossed to a constitutive Cre
expressing line, hβactin-Cre (Lewandoski and Martin, 1997). E14.5
embryos from each cross were used to produce mouse embryoniccells were transfected with either pCAG-TVA, pUbC-cTVA+ pCAG-GFP:Cre, pUbC-cTVA,
h the EnvA glycoprotein. (A) An image of a single NinII-infected clone detected by Xgal
ith DAPI-labeled nuclei (blue). The infection ratios, which are the number of clones
A 800 cells (which constitutively express TVA, (Narayan et al., 2003)) are plotted with
r CAG-GFP:Cre alone conditions were not signiﬁcantly different from each other (t-test).
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test for infectivity of NIH 3T3 cells were used to infect the MEFs. Two
questions were addressed: the efﬁciency of EnvA/TVA-mediated
infection, and the speciﬁcity of viral infection, e.g. if any viral infection
occurred when TVA should not be expressed.
MEFS from each cTVA line were infected with NinII(EnvA). Each
culture of the genotype cTVA+/Cre+was infectable with these viruses,
while all other cultures of genotypes cTVA+/Cre-, cTVA−/Cre+, and
cTVA−/Cre−were not (Fig. 3). These data indicate that the conditional
allele was working as designed. All three lines had similar infectivityFig. 3. Infection of cTVA MEFs with EnvA pseudotyped retroviruses. MEFS from three differe
dish from a TVA− /Cre−culture. (B) An image from a dish of a TVA+/Cre+ culture. Both cul
data from the infection of MEFs by NinII. Column 1 lists the culture ID number, which refer
number of infectious viral particles applied to the dish. Column 3 indicates the number of
infectious virions applied (column 2). The number of infectious virions was measured by infe
carried out with NinII(VSV-G) for comparison of efﬁciency of infection.ratios and showed no background infectivity in the absence of Cre
(data not shown).
To test how efﬁciently retroviruses with a highly promiscuous
envelope protein could infect these cells, and thus provide a comparison
for EnvA pseudotyped retroviruses, VSV-G pseudotyped retroviruses
wereused. VSV-Gmediates infection into awidevarietyof species and is
commonly used as the glycoprotein for retroviral infections (Emi et al.,
1991; Kwon et al., 2003; Yoshida et al., 1997). NinII(VSV-G) virus was
incubated with the MEF cultures and, as expected, a greater efﬁciency
was observed relative to that of the EnvA virions. The highest infectivitynt cTVA mouse lines (L1, L2, and L3) were infected with NinII(EnvA). (A) An image of a
tures were infected with the same number of NinII infectious particles. (C) Quantitative
s to an individual MEF culture, derived from a unique embryo. Column 2 indicates the
clones observed. Column 4 is the ratio of clones observed (column 3) divided by the
ction of 293TVA800 cells, which constitutively express TVA. Infections of the MEFs were
Fig. 4. Efﬁciency of infection of virus pseudotyped with EnvA vs. VSV-G. Retroviruses (LIA(EnvA) and BAG (VSV-G)) were mixed and injected into the subretinal space of P0 mice in
vivo. Retinas were analyzed for clones following the completion of development at P21, either by scoring infections on retinal whole mount preparations, or by scoring clones on
cryosections. (A) A cryosection of a retina exhibiting clones from LIA(EnvA) (arrows) and BAG (VSV-G) (arrowhead) are shown. (B) The ratio of VSV-G to EnvA events was calculated
for the four resulting genotypes of the cTVA+/− × hβactin-Cre +/− cross, as shown. The values for these calculations are listed in Table 1.
314 K.T. Beier et al. / Developmental Biology 353 (2011) 309–320of an EnvA retrovirus relative to a VSV-G enveloped retrovirus in the
MEFs was about 1:554. Though reduced, this efﬁciency may not affect
utility in the mouse, as only a small number of infection events are
desired for clonal lineage analysis.Table 1
Quantiﬁcation of clones from retinae infected with LIA(EnvA) and BAG(VSV-G). While all
four genotypes showed infection with EnvA pseudotyped virus, the cTVA+ Cre+
condition showed a twenty-three-fold enhancement of infection. Employing the t-test
with Bonferroni corrections, the number of clones observed on TVA+/Cre−,TVA−/Cre+,
and TVA−/Cre−were not signiﬁcantly different from one another.
Mouse Retina lacZ (G) PLAP (A) Total G/A ratio A clones/1000 G clones
cTVA+/Cre
11767 1 374 33 407 11.3 88.2
11767 2 885 56 941 15.8 63.2
11769 1 642 58 700 11.1 90.3
11770 1 1253 96 1349 13.1 76.6
11770 2 1515 156 1671 9.71 103
11741 1 884 55 939 16.1 62.2
11774 1 641 49 690 13.1 76.4
Total 6194 503 6697 12.3 81.2
cTVA+ /Cre−
11740 1 320 0 320 0
11740 2 398 2 400 199 5.03
11745 1 1603 6 1609 267 3.74
11771 1 199 0 199 0
11771 2 38 0 38 0
11772 1 1696 4 1700 424 2.36
11772 2 11 0 11 0
11753 1 1892 3 1895 631 1.59
11753 2 18 0 18 – 0
Total 6175 15 6190 412 2.43
cTVA− /Cre+
11754 1 81 0 81 0
11754 2 1394 3 1397 465 2.15
11773 1 10 0 103 0
11773 2 10 0 10 0
Total 1588 3 1591 529 1.89
cTVA−/Cre−
11768 1 500 1 501 500 2
11768 2 1250 15 1265 83.3 12
11749 1 644 4 648 161 6.21
11749 2 2268 24 2292 94.5 10.6
11750 1 719 1 720 719 1.39
11750 2 4552 28 4580 163 6.15
11751 1 4733 24 4757 197 5.07
11751 2 3121 13 3134 240 4.17
11754 1 70 0 70 0
11754 2 43 0 43 0
Total 17900 110 18010 163 6.15Efﬁciency and speciﬁcity of EnvA/cTVA in the retina
To use the cTVA mouse lines for in vivo lineage analysis, it was
useful to perform an in vivo characterization in a well-deﬁned system.
The retina was chosen, as extensive lineage analyses have been
performed in the retina by our laboratory in the past, providing a
robust set of data for comparison (Fields-Berry et al., 1992; Morrow
et al., 1999; Turner andCepko, 1987; Turner et al., 1990). The genesis of
retinal neurons begins at e11 and continues until P11 (Young, 1985a),
and the birthdating of these cells has been well established (Young,
1985a; Young, 1985b).
In order to test the efﬁciency of TVA/EnvA-mediated viral entry, we
ﬁrst normalized for injection efﬁciency. The efﬁciency was examined
by co-injecting an EnvA pseudotypedmurine vector encoding alkaline
phosphatase (LIA)with a VSV-G envelopedmurine vector encoding β-
galactosidase (BAG). LIA(EnvA) and BAG(VSV-G) were injected into
the mouse retinae at P0. At P21, after development was complete, the
number of clones arising from each virus was scored and analyzed.
Clones were identiﬁed as radial clusters of cells, separated from other
clusters of labeled cells. Previous studies in our laboratory, in which a
dilution series of viruses (Turner and Cepko, 1987), or mixtures of
viruses encoding distinct markers (Fekete et al., 1994; Fields-Berry
et al., 1992; Punzo and Cepko, 2008)were used, have established these
radial clusters as clones. As MEFs derived frommouse lines L1, L2, and
L3 all showed similar infectivity, L1 was used for all further analysis in
the mouse. A schematic diagram of this experiment is shown in Fig. 1.
Similar EnvA/VSV-G ratios were observed from counts made on
whole mount retinal preparations or cryosections. Additional viral
cocktails were examined and includedmixtures of nuclear/cytoplasmic
β-galactosidase, as well as NLS-tdTomato/β-galactosidase viruses. All
ratios of infection efﬁciency appeared to be consistent independent of
the viral cocktail used. Two different Cre lineswere used to activate TVA
expression — hβactin-Cre (Lewandoski and Martin, 1997), which is
ubiquitously expressed, and Chx10-Cre, which is expressed in the
majority of retinal progenitor cells during development (Rowan and
Cepko, 2004). These two Cre-expressing lines crossed to the cTVA
mouse showed similar ratios of EnvA:VSV-G infection, a ﬁnding that is
expected, given that almost all retinal cells should have a history of
expression of Cre.
The ratio of EnvA/VSV-G mediated infection events in retinae of
mice with the cTVA and Cre alleles was roughly 80:1000, or 1:12.5(Fig. 4, Table 1). Since the cocktails were each injected with an EnvA/
VSV-G ratio of 2:1, this indicates that the EnvA/TVA-mediated viral
entry was about 25 times less efﬁcient than VSV-G-mediated entry in
the P0 mouse retina. Interestingly, retinae from the cross cTVA+/− ×
hβactin-Cre+/− that should not express TVA (cTVA+/Cre−; cTVA−/
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This is in contrast to the results obtained in MEFs from the same cTVA
expressing lines. However, the results indicate that there were no
more infection events in the cTVA+/Cre− condition than in the cTVA−/
Cre+ and cTVA−/Cre− conditions, demonstrating that the infection
events were independent of the presence of Cre or TVA.
A non-zero background of EnvA infection in the absence of TVA has
been indicated previously (Wickersham et al., 2010). However, the
number of infection events observed here was over 103 higher than
previously reported. Since the previous study did not employ co-
infection with VSV-G pseudotyped virus, it seemed that the coinfection
strategy used heremight be responsible for the higher rate of EnvA virus
entry in the absence of TVA. To test this idea, retinae from P0 mice
were explanted and infected with 2.7×104 infectious EnvA pseudo-
typed BAG virions. The retinaewere kept for 3 days and subsequently
processed for β-galactosidase activity. Analysis of 26 retinae from 13
mice thatwere cTVA+/Cre−, cTVA−/Cre+, or cTVA−/Cre−showed
no Xgal staining, indicating that the virus did not infect the retinae.
Subsequently, LIA (VSV-G)was added to the same tube of BAG(EnvA)
virus used in the experiments above. Amixture of the same 2:1 EnvA/
VSV-G ratio as was used previously in vivo was used to for the
infection of the explants, which was 1 μL (2.7×104 BAG(EnvA) and
1.35×104 LIA(VSV-G) virions) per infection of a P0 retinal explant.
The presence of BAG viral infection was detected in all 11 retinae
scored that were not cTVA+/Cre+ and therefore did not express TVA
(Fig. 5). This demonstrates that, in the presence of VSV-G enveloped
retroviruses, EnvA retroviruses can infect cells in the absence of TVA
expression.Viruses with EnvA can successfully infect several tissues in the
developing cTVA mouse
As recombination rates and expression levels in transgenic mice
can be variable across tissues, wewished to explore whether the cTVA
mice would be useful for analyses in multiple tissues. To this end,
infection of two other developing tissues was carried out. The progeny
of hβactin-Cre×cTVAmice were injected in the midbrain at P2 with a
cocktail of β-galactosidase and PLAP-expressing EnvA pseudotyped
retroviruses with the aim of labeling postnatally born glial cells. In this
case, no attempt was made to perform clonal analysis, as this was
done in the past with a combination of viruses injected into this site,
albeit with virions with the MMLV ecotropic envelope protein
(Levison and Goldman, 1993). The experiment done here was to
address only whether the cTVA would recombine and express at a
sufﬁcient level for infection with EnvA-pseudotyped viruses. Mice
were allowed to develop for 3 weeks after inoculation to permit clonal
expansion and cell differentiation. Thereafter, brains were analyzedFig. 5. Test for effect of a virus with one glycoprotein on the infectivity of a virus with a differe
co-infection with VSV-G retroviruses. Retinal explants were infected with BAG(EnvA) at P0
while that in (B) was TVA+/Cre− and was infected with the same amount of infectious BAG
BAG(EnvA) and LIA(VSV-G). All retinae were stained for β-galactosidase only.for the presence of viral infection. Both astrocytes and oligodendro-
cytes labeled for either β-galactosidase or PLAP activity were observed
in cTVA+/Cre+(6/7) (Fig. 6A, B) but not cTVA+/Cre− (0/4) mice.
Astrocytes and oligodendrocytes were the predicted progeny based
upon classical birthdating studies and the previous retroviral lineage
studies (Altman, 1966; Levison and Goldman, 1993).
To investigate the utility of this tool in a line expressing Cre in amore
restricted cell population, a Wnt1-Cre mouse was crossed to a cTVA L1
mouse.Wnt1-Cre is expressed embryonically, starting at approximately
e8.5 in the neural tube (McMahon and Bradley, 1990). Areas shown to
express Wnt1 include the embryonic mesencephalon, dorsal myelen-
cephalon, and spinal cord, and later also the rhombic lip and caudal
diencephalon (Dymecki and Tomasiewicz, 1998). The early expression
domain of Wnt1-Cre ultimately gives rise to cells in the skeleton of the
head, as well as neurons in the cerebellum, midbrain, spinal cord, and
dorsal root ganglia (Dymecki and Tomasiewicz, 1998; Ikeya et al., 1997;
McMahon and Bradley, 1990; Shackleford and Varmus, 1987). As
progenitor cells with a history of Wnt1-Cre expression (and therefore
TVA-expressing) were accessible by ventricular injection at early
developmental stages, viral injections were targeted to the cycling
progenitors lining the ventricular space at e13.5. Pupswere sacriﬁced at
birth and tissues scored for virally-labeled cells. In a single litter, 4/4
cTVA+/Wnt1-Cre+ embryos had cells with evidence of LIA infection,
and other cells showing evidence of NinII infection (Fig. 6 C–E). No
embryos (0/3) that should not express TVA exhibited virally-labeled
cells. The labeled cells observed in the cTVA+/Wnt1-Cre+ positive
embryos were in the cranial skeleton, which is derived from the cranial
neural crest. As well, neurons in the hindbrain, including cerebellar
Purkinje cells, which are known to have a Wnt1-Cre history in this
transgenic line, were labeled by an injection of the QC GFP IX(EnvA)
virus (Fig. 6 F). The productive infection of TVA+ progenitor cells, and
the lack of infection in mice with no TVA in these two additional areas,
demonstrates that cTVAmice should be useful for applications in which
EnvA-pseudotyped viruses are employed, either for lineage studies, or
simply introduction of genes into speciﬁc cells with a Cre history.Multiple types of reporter viruses for marking infected cells
Coinfection with viruses that encode distinct marker genes
allowed for the comparison described above regarding the efﬁciencies
of infection with viruses with EnvA and VSV-G (Fig. 4). This same
strategy of mixing together viruses with distinct marker genes can
also be employed using viruses with the same glycoprotein in order to
enable deﬁnition of clonal boundaries. This is sufﬁcient when there is
a small or moderate amount of mixing of clones, and allows for a more
efﬁcient way to follow lineages, as one can examine multiple clones
following infection of the same animal (Cepko et al., 1993; Fields-nt glycoprotein. EnvA retroviruses were used to infect retinal explants with andwithout
. The retina in (A) was TVA+/Cre+ and was infected with BAG(EnvA) retrovirus only,
(EnvA) virus. The retina in (C) was also TVA+/Cre−, but was infected with a mixture of
Fig. 6. Infection of mouse brains with LIA and NinII pseudotyped with EnvA. P2 mouse pups of the cross cTVA+/− × hβactin-Cre+/−were injected in the subventricular zone of the
midbrain and sacriﬁced at P28. Coronal sections were made and stained histochemically for PLAP and β-galactosidase activity. The area of the sections is indicated in the highlighted
area of the embedded cartoon. Both viruses labeled oligodendrocytes (A, arrow) and astrocytes (B, arrow), glial types known to be produced postnatally. Viral labeling was only seen
in animals with TVA and Cre; all other genotypes of this cross were negative. Wnt1-Cre+/−mice were crossed to cTVA+/−mice, and the embryos were injected in utero into the
third ventricle with LIA(EnvA) and NinII(EnvA), or QC NLS-GFP IX(EnvA) (C–F). The embedded cartoons show the area of the sections that are shown. Cells in the cranial skeleton
that are descended fromWnt1 expressing progenitor cells, infected by LIA(EnvA) (arrow in D), NinII(EnvA) (arrowhead in D), or QC NLS-GFP IX(EnvA) (E) in cTVA+/Cre+mice, are
shown. Neurons also were labeled, as demonstrated by labeled Purkinje cells (F), generated by infection with QC NLS-GFP IX(EnvA). Injections into TVA− or Cre− animals were
negative.
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Peters and Cepko, 2002). When an extreme amount of migration
causes clones to be completely intermingled, infection with a few
types or markers is not sufﬁcient, and the use of viral libraries with,
e.g. N102 genetic tags, is required (Cepko et al., 1998; Golden et al.,
1995; Walsh and Cepko, 1992). Beyond enabling clonal assignments,
viruses with distinct histochemical or ﬂuorescent reporters enable
different types of assays for detection of infected cells, and for co-
labeling of infected cells with cell type-speciﬁc antibodies. To this end,
a number of replication-incompetent retroviruses were created and
tested in several combinations.A nuclear, cytoplasmic, and membrane version of ﬂuorescent
reporters, including, CFP, GFP, YFP, Kusabira Orange, tdTomato, and
mCherry (Shaner et al., 2005) were made and tested. In addition to
viruses encoding ﬂuorescent reporters, the viruses encoding histo-
chemically detectable enzymes, such as nuclear or cytoplasmically
localized β-galactosidase, and membrane-bound PLAP, can be
combined with each other and/or with the ﬂuorescent reporter
viruses. For examples, we tested several combinations, as shown in
Fig. 7. It is worth noting that the combinations shown in Fig. 7 were
not meant to highlight clonal boundaries: high concentrations of
viruses were used so that a comparison of cells infected with different
Fig. 7. Retroviruses with distinct histochemical and ﬂuorescent reporters. Combinations of BAG, LIA, and QC viruses were injected in vivo into the subretinal space of P0 retinas, and
the retinas were examined at P21. The reporter combinations shown are (A) GFP (anti-GFP, in green, arrowhead), mCherry (anti-RFP, in red, arrow), and BAG (anti-β-galactosidase,
in blue, chevron), (B), GFP (anti-GFP, in green, arrowhead) and BAG (anti-β-galactosidase, in magenta, arrow) (C), tdTomato (anti-RFP, in red, arrow) and BAG (anti-β-galactosidase,
in blue, arrowhead), (D) GFP (anti-GFP, in green, arrowhead) and tdTomato (anti-RFP, in red, arrow), (E) NinII (anti-β-gal, in green, arrowhead) and BAG (anti-β-gal, in green,
arrow) with Chx10-NLS-GFP, a gene in the transgenic background, marking bipolar cell nuclei. The retinal layers are labeled in panels A–E as follows: ONL=outer nuclear layer,
INL=inner nuclear layer, GC=ganglion cell layer. Panels F–I show images of infected 293T cells. These combinations are: (F) membrane Cerulean (blue, chevron), Venus (green,
arrowhead), and NLS-mCherry (red, arrow), (G) NLS-GFP (green, arrowhead) and membrane tdTomato (red, arrow), (H) NLS-tdTomato (red, arrow) and membrane YFP (yellow,
arrowhead), and (I) membrane Kusabira Orange (orange, arrow) and NLS-CFP (blue, arrowhead).
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of clonal boundaries, one would use many fewer viral particles, and
for added conﬁdence, a dilution series would be run (e.g. see Turner
and Cepko, 1987).
The examples in Fig. 7 illustrate the advantages of several of these
reporter viruses and their combinations. Fluorescent viral reporters
provide a fairly easy way to deﬁne clonal boundaries. Several viruses
with distinct ﬂuorescent properties can be made using the expanding
palette of ﬂuorescent reporters, and then one can use a single type of
tissue preparation and microscopy to simultaneously detect different
clones (Fig. 7 F–I). This does require a level of expression sufﬁcient for
detection of the ﬂuorescent proteins, without immunohistochemical
detection. When reporter expression from the viral genome is not
sufﬁciently bright, one can use antibodies to give each protein a
different color. For example, in Fig. 7A, the ﬂuorescence of already
ﬂuorescent GFP and mCherry was enhanced by the use of antibodies,
and the non-ﬂuorescent β-galactosidase enzyme was detected by a β-
galactosidase antibody, whose signal was converted into Cy5
ﬂuorescence. Depending on which cocktail of viruses is used, the
detection of β-galactosidase can be computationally converted into
magenta (Fig. 7B) or blue (Fig. 7 C), making quantiﬁcation easier. The
combinations of viruses that will be useful for a particular applicationwill depend upon the requirements for a particular experiment, as
discussed further in the Discussion.
Discussion
Clonal analysis of cells with a speciﬁc gene expression history
The goal of this study was to evaluate the utility of the cTVAmouse
as ameans tomap lineages from progenitor cells with a speciﬁed gene
expression history. Integrating the high spatial and temporal
resolution of viral infection with gene expression history, the cTVA
mouse permits a ﬁner analysis of the relationships between gene
expression history and lineage relationships. Viruses can be injected
into a particular location at different times throughout development
in order to generate a lineage tree from cells with a speciﬁc gene
expression history. Any existing Cre line can be used. Alternatively,
viruses encoding Cre, e.g. Adenovirus with a cell type-speciﬁc
promoter driving Cre (Maeda et al., 2006), can also be used in
conjunction with the cTVA allele. Clones also can be generated by
infecting cells with expression of TVA driven directly by a promoter,
e.g. not cells with a Cre history, but cells that currently express TVA
from a particular promoter. This allows one to build lineage trees
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of Cre, as compared to those with current expression from a speciﬁc
promoter. For this type of analysis, one can again use Adenoviruses, or
any other vector, to drive expression of TVA using speciﬁc promoters,
or use engineered mouse strains (Fisher et al., 1999; Holland and
Varmus, 1998; Montaner et al., 2003; Orsulic et al., 2002).
The cTVA mice can be used to generate either broad or narrow
patterns of TVA expression, and viruses with different titers can be
used to deliver genes to a few or many TVA-expressing cells. The
replication-competent avian vectors (RCAS) generated by Hughes et
al. (1987) typically grow to higher titers than replication-incompetent
vectors. When one wishes to transduce a gene or an shRNA into cells
with TVA expression, rather than perform clonal lineage analysis, high
titered preparations of RCAS vectors can be employed to infect more
cells. For example, RCASwasused to deliver oncogenes to glial cells in a
transgenic mouse which used a glial promoter (GFAP) to drive TVA
expression, to create murine models of glioblastoma (Holland and
Varmus, 1998; Holland et al., 1998). The ﬂexibility of this system also
allows use of other viruses with an EnvA protein, as many small
enveloped viruses are promiscuous regarding their envelope proteins.
For example, Wickersham et al. showed that rabies virus pseudotyped
with a fusion protein of EnvA and the rabies glycoprotein could enter
cells through TVA (Wickersham et al., 2007). We have also used
lentiviral vectors pseudotyped with EnvA. This broadens the applica-
tions that are possible as lentiviruses can infect neurons and other
postmitotic cells (Lewis et al., 2001).Efﬁciency of EnvA-mediated infection
We observed infection by EnvA pseudotyped viruses in the mouse
through TVA, as indicated in previous studies (Fisher et al., 1999;
Holland and Varmus, 1998; Seidler et al., 2008). We were able to
further investigate the efﬁciency of this phenomenon quantitatively in
vivo and in vitro. By counting clones generated by infection with a
cocktail of known titers of EnvA and VSV-G pseudotyped retroviruses,
a relative efﬁciency could be calculated. Additionally, we determined
the speciﬁcity of EnvA enveloped virus infection for murine cells in
vivo and in vitro. If injected alone, the infectivity of EnvA viruses to
non-TVA expressing cells was negligible using a number of virions
typically used for standard retroviral infections (105 or fewer virions).
No infection was observed in all MEF cultures and brains that did not
have TVA expression. In the case of the NIH 3T3 cells, there was some
background infection when TVA should not have been expressed. This
was not due to a problemwith the TVA allele being leaky, as the same
level of expression was seen in cells that did not have the TVA
transgene. The reason(s) for this low level of infectivity in certain
tissues and cell lines is unclear, but these observations dictate that
one should perform proper controls for each new cell line or tissue
tested.
In addition to speciﬁcity, it is useful to know the efﬁciency of viral
infection. This was measured by comparing the infection rates of cells
transfected with CAG-TVA or cTVA plus a Cre plasmid. The cTVA+ Cre
combination was less efﬁcient in mediating EnvA enveloped viral
infection than CAG-TVA, despite equal transfection efﬁciencies and
100% co-transfection efﬁciency. This difference is likely due to
different TVA expression levels, as TVA is driven by the CAG promoter
in the CAG-TVA plasmid, and cTVA is driven by the human UbC
promoter. In vivo, we found that the efﬁcacy of TVA-mediated viral
entry was roughly 25-fold lower than VSV-G-mediated viral entry in
the retina, and inMEF cultures, it was about 550 times lower thanVSV-
Gmediated entry. A similar reduction of infection efﬁciency of murine
cells by EnvA pseudotyped viruses has been previously observed
(Lewis et al., 2001). Infection of MEFs was particularly inefﬁcient, for
reasons that are unclear, but may be similar to the reasons discussed
below.Reduced efﬁciency of infection by EnvA pseudotyped viruses in the
developing mouse may be due to a number of causes. In the retina,
perhaps the TVA receptor is not present on the processes of progenitor
cells extending into the subretinal space, where the viruses are
injected, or where the processes are exposed to the medium, in the
case of retinal explants. The expression of TVA from the UbC promoter
might also be poor, though low levels of TVA have been reported to be
sufﬁcient for infection (Federspiel et al., 1994). It is also possible that
EnvA-mediated entry simply does not give rise to as many infectious
integration events in vivo as does VSV-G-mediated entry. For example,
VSV-G fusion occurs in the early endosomes (Le Blanc et al., 2005; Sun
et al., 2005; Sun et al., 2008), whereas EnvA appears to fuse after entry
into the lysosome (Mothes et al., 2000). This could lead to increased
genome degradation or alteration of the viral life cycle. It has been
previously demonstrated that the infectivity of retroviruses is
dependent on the mechanism of entry (Narayan et al., 2003). The
further reduced ratio in the MEFs may be due to a limited receptor
expression and a low probability of receptor:glycoprotein interaction.
At 37 °C, MMLV virions quickly decay; the half-life is less than 6 h
(Kwon et al., 2003). When injected subretinally, the virus has much
less space to diffuse, and its envelope protein may more frequently
contact its cognate receptor than in the MEFs. The reduced efﬁciency
in MEFs may also be a reﬂection of differences between primary cells
and immortalized cells or developing tissues.
A few differences between EnvA and VSV-G should be noted. VSV-
G is often used for its efﬁciency and ability to expand the host range
of retroviruses (Burns et al., 1993; Emi et al., 1991; Hopkins, 1993;
Yoshida et al., 1997). The VSV-G protein allows VSV to infect a wide
range of species and cell types, from invertebrates through verte-
brates, and it has been speculated to have a phospholipid for its
receptor, though this is not entirely clear (Lyles and Rupprecht, 2007).
This is in contrast to EnvA pseudotyped viruses, which can only infect
cells expressing the TVA receptor. Viral glycoproteins associate with
their cognate receptors (or phospholipids) according to their
equilibrium constants (Battini et al., 1996; Yu et al., 1995). Since
phospholipids are much more abundant than protein surface
receptors, a larger fraction of EnvA virions may remain unassociated
with cells. Therefore, both in terms of the number of cells susceptible,
as well as cellular and receptor topology, it is expected that VSV-G-
mediated viral entry would be more efﬁcient than EnvA-mediated
infection. It is also of note that the standardmethod of viral titering, as
determined in cell culture, is not always an accurate measure of the
number of infectious retroviral particles. Discrepancies such as target
cell type and number, the presence of polycations, temperature, and
exposure time may all make titers somewhat inconsistent (Kwon
et al., 2003). Mathematical models, as previously demonstrated
(Kwon and Peng, 2002), could be used to more accurately determine
the initial concentration of infectious retroviruses, which may yield
different ratios in the assays used herein (Chen et al., 1999; Emi et al.,
1991; Kwon et al., 2003; Ory et al., 1996; Yang et al., 1995).
A novel mechanism of viral entry
We observed that EnvA viruses could infect non-TVA expressing
cells when co-injected with VSV-G enveloped viruses. The infection
ratio was roughly 1:23 when infection with an EnvA virus was
performed on cTVA+/Cre−, cTVA−/Cre+, and cTVA−/Cre− mouse
cells relative to the cTVA+/Cre+ condition. These data were not in
agreement with the data from infection of the MEFs derived from the
cTVA mice, where no infection of EnvA viruses was observed on non-
TVA expressing cells. We realized that the difference was likely the
inclusion of the VSV-G enveloped control virus with the EnvA virus in
the experiments that showed infection of non-TVA expressing cells.
We hypothesized that there might be an association between the
virions with the different glycoproteins. Indeed, when exclusively
EnvA viruses were used to infect a retina that did not express TVA, no
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an association between membranes containing different envelope
proteins that permitted entrance of EnvA virions into otherwise non-
permissible cells. By this hypothesis, if a VSV-G enveloped virus
carried an EnvA virus into the cell, once inside, either viral genome
could integrate. If the viral genome pseudotyped with VSV-G
integrated, this would be scored as a VSV-G mediated event, and if
the EnvA pseudotyped viral genome integrated, as an EnvA-mediated
event. It is also possible that both genomes would integrate into the
same cell, and both markers would be seen. However, this event is
unlikely, as the majority of retroviral particles are non-infectious. As
the particle:infectious particle ratio is 143:1 (Kwon et al., 2003), the
chance of successful co-integration is about 104. This means that
only one histochemical marker would likely be detected in these
cells. In accord with this calculation, in no instance was a double β-
galactosidase/PLAP labeled cell observed.
This series of experiments led to the identiﬁcation of a novelmeans
of viral entry, whereby EnvA retroviruses entered and infected cells by
a non-TVA mediated pathway. From a practical standpoint, this
phenomenon is worth being aware of in terms of planning experi-
ments. From a virology standpoint, it is of interest to understand how
viral entry is mediated for one virus by another.Cocktails of viruses with distinctive reporter genes
We have created a number of novel replication-incompetent
retroviruses for use in lineage analyses and other types of cell marking
applications, such as the labeling of dividing cells in a tissue. Both
ﬂuorescent proteins and genes encoding enzymes that can yield
colored precipitates from histochemical reactions are of use in these
applications. Fluorescent reporters have multiple advantages, includ-
ing imaging in live tissue. They allow one to screen tissue for infection
prior to performing histological analyses. They can be readily
combined with detection methods aimed at deﬁning a cell type
using antibodies and ﬂuorescent immunohistochemistry. However, as
viral infection leads to only a single copy of the genome, ﬂuorescent
proteins are not always expressed at a high enough level to give
robust staining of all cells, or all aspects of the deﬁning morphological
characteristics of a cell. This can be overcome with immunohisto-
chemical detection of GFP and its derivatives. This however limits the
number of such GFP-derivative viruses that can be used in
combination, unless one uses combinations that target distinct cell
compartments, e.g. membrane-bound, nuclear, and/or cytoplasmic.
As we have made various targeted versions of each ﬂuorescent
protein, this might sufﬁce for some applications.
The viruses encoding β-galactosidase and PLAP offer the greatest
sensitivity for detection of infected cells. In addition, they provide for a
very stable label following histochemical detection with Xgal or BCIP/
NBT. These reaction products have been stable in stained sections
stored at room temperature for at least 7 years in our laboratory. In
addition to sensitivity, the histochemical detection methods offer
another advantage. Both β-galactosidase and PLAP enzymatic assays
can be rapidly and easily carried out, and make the cells easy to detect
and score, even in thick tissue sections or whole mount preparations.
However, if one wishes to combine immunohistochemistry for a cell
type-speciﬁc protein in order to better deﬁne an infected cell stained
with e.g. BCIP/NBT used to detect PLAP, it is difﬁcult to do so. The BCIP/
NBT reaction products absorb most wavelengths of light, making
ﬂuorescent detection of the cell type-speciﬁc protein very difﬁcult.
Similarly, the histochemical reaction products can be very dark and it
is difﬁcult to see e.g. HRP reaction products on top of the BCIP/NBT or
Xgal reaction products. One way to circumvent this problem is to use
nuclear β-galactosidase combined with immunohistochemical detec-
tion of a membrane or cytoplasmically localized cell type-speciﬁc
protein. In addition, there are excellent commercial antibodies forboth β-galactosidase and PLAP, permitting immunoﬂuorescent label-
ing of cells infected with viruses encoding these genes, and thus
double immunoﬂuorescent detection of the viral label and a cell type-
speciﬁc protein is possible. These vectors will be freely available
from Addgene (http://www.addgene.org) and thus investigators can
ﬁnd optimal combinations of the different vectors for their own
applications.
We conclude that the cTVA mice are useful for lineage analysis
of cells with a particular gene expression history. The mice permit
speciﬁc infection of cells with a Cre expression history, and no
background was observed in any tissue injected with EnvA virions
alone. In addition to lineage analysis, thesemice offer away to introduce
genes into cells with a speciﬁc gene expression history. For example,
viruses carrying shRNAs or gain of function constructs can be delivered
to only a subset of cells in a tissue, thosewith a history of Cre expression.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.03.004.
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